Related Experiment Video
Updated: May 1, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
HIV treatment outcomes in Europe and North America: what can we learn from the differences?
Juan Ambrosioni1, David Nicolas, Fernando Agüero
1Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Abstract:
The access to antiretroviral treatment has been largely enlarged in Europe and North America in recent years, due to treatment guidelines that recommend earlier initiation of therapy. However, there are differences and heterogeneities in the health systems and in access and retention to care between different countries and regions, and for different subpopulations among the same country that impact in the final goal, that patients remain undetectable and in good health.
Related Concept Videos
Retrovirus Life Cycles
Clinical Trials: Overview
Treatment Resistant Cancers
Therapeutic Drug Monitoring: Affecting Factors
Clinical Trials
There are four phases in a clinical trial. A phase one...
Factors Affecting Drug Response: Overview

